These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 17785863

  • 21. Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma.
    Smith KE, Janelidze S, Visse E, Badn W, Salford L, Siesjö P, Darabi A.
    Int J Cancer; 2007 Jan 01; 120(1):75-80. PubMed ID: 17044023
    [Abstract] [Full Text] [Related]

  • 22. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
    Smith KE, Fritzell S, Badn W, Eberstål S, Janelidze S, Visse E, Darabi A, Siesjö P.
    Int J Cancer; 2009 Feb 01; 124(3):630-7. PubMed ID: 18972433
    [Abstract] [Full Text] [Related]

  • 23. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    Chirasani SR, Leukel P, Gottfried E, Hochrein J, Stadler K, Neumann B, Oefner PJ, Gronwald W, Bogdahn U, Hau P, Kreutz M, Grauer OM.
    Int J Cancer; 2013 Feb 15; 132(4):843-53. PubMed ID: 22752934
    [Abstract] [Full Text] [Related]

  • 24. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.
    Visse E, Siesjö P, Widegren B, Sjögren HO.
    Cancer Gene Ther; 1999 Feb 15; 6(1):37-44. PubMed ID: 10078962
    [Abstract] [Full Text] [Related]

  • 25. Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas.
    Hegardt P, Widegren B, Sjögren HO.
    Cell Immunol; 2000 Mar 15; 200(2):116-27. PubMed ID: 10753503
    [Abstract] [Full Text] [Related]

  • 26. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug 15; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 27. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    Maccallini C, Di Matteo M, Gallorini M, Montagnani M, Graziani V, Ammazzalorso A, Amoia P, De Filippis B, Di Silvestre S, Fantacuzzi M, Giampietro L, Potenza MA, Re N, Pandolfi A, Cataldi A, Amoroso R.
    Eur J Med Chem; 2018 May 25; 152():53-64. PubMed ID: 29689474
    [Abstract] [Full Text] [Related]

  • 28. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
    Vermeire K, Thielemans L, Matthys P, Billiau A.
    J Leukoc Biol; 2000 Jul 25; 68(1):119-24. PubMed ID: 10914498
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.
    Fujita M, Zhu X, Sasaki K, Ueda R, Low KL, Pollack IF, Okada H.
    J Immunol; 2008 Feb 15; 180(4):2089-98. PubMed ID: 18250414
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.
    Read SB, Kulprathipanja NV, Gomez GG, Paul DB, Winston KR, Robbins JM, Kruse CA.
    J Interferon Cytokine Res; 2003 Jul 15; 23(7):379-93. PubMed ID: 14511464
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.
    Jia W, Jackson-Cook C, Graf MR.
    J Neuroimmunol; 2010 Jun 15; 223(1-2):20-30. PubMed ID: 20452681
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
    Jayaraman P, Alfarano MG, Svider PF, Parikh F, Lu G, Kidwai S, Xiong H, Sikora AG.
    Clin Cancer Res; 2014 Dec 15; 20(24):6439-51. PubMed ID: 25278453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.